161 related articles for article (PubMed ID: 16231362)
1. The effects of bone therapy on tibial bone loss in young women with anorexia nervosa.
Nakahara T; Nagai N; Tanaka M; Muranaga T; Kojima S; Nozoe S; Naruo T
Int J Eat Disord; 2006 Jan; 39(1):20-6. PubMed ID: 16231362
[TBL] [Abstract][Full Text] [Related]
2. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
3. [Bone metabolism disturbances in anorexia nervosa].
Szymańska U; Jagielska G; Tomaszewicz-Libudzic C; Przedlacki J
Wiad Lek; 2007; 60(1-2):68-72. PubMed ID: 17607972
[TBL] [Abstract][Full Text] [Related]
4. [Anorexia nervosa and its consequences on bone: a therapeutic challenge].
Trombetti A; Richert L; Rizzoli R
Rev Med Suisse; 2007 Jun; 3(115):1502-5. PubMed ID: 17682792
[TBL] [Abstract][Full Text] [Related]
5. Osteoclast inhibitory effects of vitamin K2 alone or in combination with etidronate or risedronate in patients with rheumatoid arthritis: 2-year results.
Morishita M; Nagashima M; Wauke K; Takahashi H; Takenouchi K
J Rheumatol; 2008 Mar; 35(3):407-13. PubMed ID: 18260178
[TBL] [Abstract][Full Text] [Related]
6. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
7. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume.
Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K
Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
9. [Effect of oral biphosphonates in patients with cystic fibrosis and low bone mineral density].
Ringuier B; Leboucher B; Leblanc M; Troussier F; Duveau E; Audran M; Giniès JL
Arch Pediatr; 2004 Dec; 11(12):1445-9. PubMed ID: 15596332
[TBL] [Abstract][Full Text] [Related]
10. [The role of a pediatric endocrinologist in diagnostics and therapeutic management of anorexia nervosa--own experiences and review of literature].
Roztoczyńska D; Starzyk J
Przegl Lek; 2009; 66(1-2):52-7. PubMed ID: 19485257
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and treatment options for bone loss in anorexia nervosa.
Grinspoon S; Herzog D; Klibanski A
Psychopharmacol Bull; 1997; 33(3):399-404. PubMed ID: 9550884
[TBL] [Abstract][Full Text] [Related]
12. Effect of risedronate on high-dose corticosteroid-induced bone loss in patients with glomerular disease.
Kikuchi Y; Imakiire T; Yamada M; Saigusa T; Hyodo T; Kushiyama T; Higashi K; Hyodo N; Yamamoto K; Suzuki S; Miura S
Nephrol Dial Transplant; 2007 Jun; 22(6):1593-600. PubMed ID: 17041001
[TBL] [Abstract][Full Text] [Related]
13. Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.
Arase Y; Suzuki F; Suzuki Y; Akuta N; Kobayashi M; Kawamura Y; Yatsuji H; Sezaki H; Hosaka T; Ikeda K; Kumada H
J Med Virol; 2008 Jul; 80(7):1302-7. PubMed ID: 18461628
[TBL] [Abstract][Full Text] [Related]
14. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
15. Etidronic acid and steroid therapy: new indication. No proven impact on fractures.
Prescrire Int; 1999 Aug; 8(42):111-2. PubMed ID: 11503828
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in bone and reproductive health in adolescents with anorexia nervosa.
Jayasinghe Y; Grover SR; Zacharin M
BJOG; 2008 Feb; 115(3):304-15. PubMed ID: 18190366
[TBL] [Abstract][Full Text] [Related]
17. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
[TBL] [Abstract][Full Text] [Related]
18. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol.
Fujita T; Orimo H; Inoue T; Kaneda K; Sakurai M; Morita R; Yamamoto K; Sugioka Y; Inoue A; Takaoka K; Yamamoto I; Hoshino Y; Kawaguchi H
J Bone Miner Metab; 2007; 25(2):130-7. PubMed ID: 17323183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
